A Study of ALS-4 in Healthy Adults Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

March 20, 2021

Primary Completion Date

December 22, 2021

Study Completion Date

January 2, 2022

Conditions

Healthy Subject

Interventions

DRUG

ALS-4

Single dose of ALS-4 before Breakfast

DRUG

Placebo

Single dose of placebo before Breakfast

DRUG

ALS-4

Dose three separate times in crossover fashion: (1) fasted morning dose; (2) fed morning dose; (3) fasted evening dose

DRUG

ALS-4

Multiple dose of ALS-4 up to two times daily

DRUG

Placebo

Multiple dose of placebo up to two times daily

Trial Locations (1)

BioPharma Services Inc., North York

All Listed Sponsors

lead

Aptorum International Limited

INDUSTRY

NCT05274802 - A Study of ALS-4 in Healthy Adults Subjects | Biotech Hunter | Biotech Hunter